Citable company snapshot
Medtronic's latest SEC-sourced 2026-07-31 period shows $9.76B in revenue and $1.47B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jul 31, 2026 | $9.76B | $9.81B | -0.5% |
| Gross Profit | Apr 24, 2020 | $3.73B | $5.32B | -29.8% |
| Operating Income | Jul 31, 2026 | $1.76B | $1.87B | -5.8% |
| Net Income | Jul 31, 2026 | $1.47B | $1.24B | +18.2% |
| Operating Cash Flow | Jul 31, 2026 | $1.79B | $2.57B | -30.3% |
| Free Cash Flow (computed) | Jul 31, 2026 | $1.29B | $2.08B | -38.1% |
Source: SEC EDGAR financial statements; period Jul 31, 2026; filed Sep 3, 2026; accession 0001628280-26-060473.
MDT company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.